IDO1 and neoplasm: Immunosuppression was observed by eosinophils-derived indoleamine 2,3-dioxygenase (IDO) (inhibition of effector T cells) and by an increasing of IL-4 and IL-13-expression by eosinophils via TSLP leading to conversion of macrophages into tumour-promoting activation state.